DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 51410-30-1, Catalin sodium, Pirenoxine sodium salt, Sodium 1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylate, 95ju7urf64, Sodium;1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylate

Molecular Formula

C₁₆H₇N₂NaO₅

Molecular Weight

330.23 g/mol

InChI Key

HDQXPMXHXZNPKE-UHFFFAOYSA-M

FDA UNII

95JU7URF64

1 2D Structure

Pirenoxine Sodium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

sodium;1,5-dioxo-4H-pyrido[3,2-a]phenoxazine-3-carboxylate

2.1.2 InChI

InChI=1S/C16H8N2O5.Na/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12;/h1-6H,(H,18,19)(H,21,22);/q;+1/p-1

2.1.3 InChI Key

HDQXPMXHXZNPKE-UHFFFAOYSA-M

2.1.4 Canonical SMILES

C1=CC=C2C(=C1)N=C3C(=CC(=O)C4=C3C(=O)C=C(N4)C(=O)[O-])O2.[Na+]

2.2 Other Identifiers

2.2.1 UNII

95JU7URF64

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 51410-30-1

2. Catalin Sodium

3. Pirenoxine Sodium Salt

4. Sodium 1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylate

5. 95ju7urf64

6. Sodium;1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylate

7. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-, Monosodium Salt

8. Sodium 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylate

9. Clarvisan (tn)

10. Ncgc00167452-01

11. Einecs 257-181-6

12. Unii-95ju7urf64

13. Pirfenoxone Sodium

14. 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid Sodium Salt

15. Dsstox_cid_26637

16. Dsstox_rid_81783

17. Dsstox_gsid_46637

18. Pirfenoxone Sodium Salt

19. Schembl1650064

20. Chembl2359957

21. Dtxsid1046637

22. Schembl11579562

23. Pirenoxine Sodium [mart.]

24. Pirenoxine Sodium [who-dd]

25. Bcp12124

26. Pirenoxine Sodium Salt [mi]

27. Tox21_112456

28. Akos015951393

29. Cas-51410-30-1

30. D08388

31. W-105897

32. Q27271800

33. (5-methyl-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol

34. Sodium 1,5-dioxo-1,5-dihydro-4h-pyrido[3,2-a]phenoxazine-3-carboxylate

35. Sodium 1-hydroxy-5-oxo-5h-pyrido(3,2-a)(phenoxazine-3-carboxylate

36. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-, Sodium Salt (1:1)

2.4 Create Date

2008-02-05

3 Chemical and Physical Properties

Molecular Formula	C₁₆H₇N₂NaO₅
Molecular Weight	330.23 g/mol
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	1
Exact Mass	330.02526561 g/mol
Monoisotopic Mass	330.02526561 g/mol
Topological Polar Surface Area	108 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	777
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2